Inhalation & Respiratory Drug Delivery

Philip Morris International

Philip Morris is the leading international Tobacco Company with the objectives to be environmentally and socially responsible. Their mission is to operate with integrity, and focus on responsibly delivering long-term, sustainable growth.

Philip Morris supports effective evidence-based regulation of tobacco products and invests in developing and assessing products with the potential to reduce the risk of tobacco-related disease. Over 82,000 people from all five continents, speaking more than 80 languages, make up the success of their company.

Munit

MUNIT is a new and innovative consultancy company, operating in the field of MICRONIZATION of Active Pharmaceutical Ingredients (APIs), High Potent APIs, Cytotoxic and Cytostatic compounds, Inhalation products, Steroids, R&D compounds and Generics. In MUNIT we have combined the technical and commercial expertise of its affiliates Jetpharma SA (Switzerland) and Microchem Srl (Italy) making the best out of 40 years of leadership.

Microbiome Series

BaseClear B.V.

BaseClear is an independent contract research laboratory for DNA-based analyses. For all areas in which DNA plays a key role, BaseClear offers convenient and high-quality solutions since 1993.

BaseClear distinguishes itself by having a highly customer-oriented approach, direct communication and a close collaboration with our customers to develop solutions specifically matched to their needs.

Symprove

Symprove was born in 2002, founded in the belief that recovering and maintaining a healthy gut balance can help you live a fuller life. We hold that same belief today, but have stayed curious in the years since, dedicated to researching the microbiome and developing the Symprove formula.

ProDigest BVBA

ProDigest's services in the field of gastrointestinal transit, bioavailability and metabolism are based on the application of an extensive in vitro technology platform which was developed at LabMET and which is organized round a dynamic simulation model of the gastrointestinal tract, called the Simulator of the Human Intestinal Microbial Ecosystem (SHIME). This technology platform is combined with a wide range of in vitro assays, animal trials and proof-of-concept human intervention studies.

From in vitro to human trials: a complete approach to test or to jointly develop our customers' products.